3/7/25 :: VROCKSTAR :: GAMB
Hit my "would like to own" zone
- we're in the hand grenades and not sniper market
- cash gen here great. good mgns.
- small cap, good growth
- like the CEO
- hit my "would buy" zone today
- i'm allocating about 20% of my book to 1-2.5% positions this year that i plan to rent out (covered calls) when the mkt finds some form of bottom/ move
- even tho "everything" has 20-30% downside potential, the goal is to avoid the -50% + type names and know what i own
- for that reason my book remains
- OBTC 40%, NXT ITM LEAPS 35%, i keep bouncing between NVDA/TSM... but think TSM keeps me more protected on downside magnitude w/ clear visibility for upside (avgo result highlights why... "unlimited" demand for this fab)
- lmk if u see differently on $GAMB. I still like
EVVTY more, but don't like the fact that i can't sell calls on it.
V
Hit my "would like to own" zone
- we're in the hand grenades and not sniper market
- cash gen here great. good mgns.
- small cap, good growth
- like the CEO
- hit my "would buy" zone today
- i'm allocating about 20% of my book to 1-2.5% positions this year that i plan to rent out (covered calls) when the mkt finds some form of bottom/ move
- even tho "everything" has 20-30% downside potential, the goal is to avoid the -50% + type names and know what i own
- for that reason my book remains
- OBTC 40%, NXT ITM LEAPS 35%, i keep bouncing between NVDA/TSM... but think TSM keeps me more protected on downside magnitude w/ clear visibility for upside (avgo result highlights why... "unlimited" demand for this fab)
- lmk if u see differently on $GAMB. I still like
EVVTY more, but don't like the fact that i can't sell calls on it.V
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.